Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Atara Biotherapeutics (ATRA) Income towards Parent Company (2022 - 2026)

Atara Biotherapeutics filings provide 5 years of Income towards Parent Company readings, the most recent being -$4.1 million for Q1 2026.

  • On a quarterly basis, Income towards Parent Company fell 110.91% to -$4.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$42.2 million, a 169.83% decrease, with the full-year FY2025 number at -$49000.0, up 99.94% from a year prior.
  • Income towards Parent Company hit -$4.1 million in Q1 2026 for Atara Biotherapeutics, up from -$36.1 million in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of $38.0 million in Q1 2025 to a low of -$88.1 million in Q1 2022.
  • Median Income towards Parent Company over the past 5 years was -$31.8 million (2024), compared with a mean of -$35.0 million.
  • Biggest five-year swings in Income towards Parent Company: crashed 485.08% in 2023 and later soared 219.71% in 2025.
  • Atara Biotherapeutics' Income towards Parent Company stood at -$74.7 million in 2022, then grew by 18.72% to -$60.7 million in 2023, then surged by 79.09% to -$12.7 million in 2024, then plummeted by 184.75% to -$36.1 million in 2025, then soared by 88.53% to -$4.1 million in 2026.
  • The last three reported values for Income towards Parent Company were -$4.1 million (Q1 2026), -$36.1 million (Q4 2025), and -$4.3 million (Q3 2025) per Business Quant data.